Article
grlA and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofloxacin- methicillin-resistant Staphylococcus aureus.
European journal of medical research - 18 Aug 2008
Coskun-Ari F F, Bosgelmez-Tinaz G
Abstract excerpt
OBJECTIVE: To determine grlA and gyrA mutations in ciprofloxacin- methicillin-resistant Staphylococcus aureus isolates and their susceptibility to current antimicrobials, including a newer fluoroquinolone gatifloxacin, glycopeptides vancomycin, teicoplanin and oxazolidinone linezolid. METHODS: A total of 56 methicillin-resistant S. aureus (MRSA) isolates were collected during 2003-2006 from inpatients of Süleyman...
Topics
- Anti-Infective Agents
- Ciprofloxacin
- DNA Gyrase
- Drug Resistance, Bacterial
- Electrophoresis, Agar Gel
- Escherichia coli
- Escherichia coli Proteins
- Fluoroquinolones
- Gatifloxacin
- Gene Expression Regulation, Bacterial
